Amplifying the Heat Shock Response Ameliorates ALS and FTD Pathology in Mouse and Human Models
Open Access
- 29 July 2023
- journal article
- research article
- Published by Springer Nature in Molecular Neurobiology
- Vol. 60 (12) , 6896-6915
Abstract
Amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) are now known as parts of a disease spectrum with common pathological features and genetic causes. However, as both conditions are clinically heterogeneous, patient groups may be phenotypically similar but pathogenically and genetically variable. Despite numerous clinical trials, there remains no effective therapy for these conditions, which, in part, may be due to challenges of therapy development in a heterogeneous patient population. Disruption to protein homeostasis is a key feature of different forms of ALS and FTD. Targeting the endogenous protein chaperone system, the heat shock response (HSR) may, therefore, be a potential therapeutic approach. We conducted a preclinical study of a known pharmacological amplifier of the HSR, called arimoclomol, in mice with a mutation in valosin-containing protein (VCP) which causes both ALS and FTD in patients. We demonstrate that amplification of the HSR ameliorates the ALS/FTD-like phenotype in the spinal cord and brain of mutant VCP mice and prevents neuronal loss, replicating our earlier findings in the SOD1 mouse model of ALS. Moreover, in human cell models, we demonstrate improvements in pathology upon arimoclomol treatment in mutant VCP patient fibroblasts and iPSC-derived motor neurons. Our findings suggest that targeting of the HSR may have therapeutic potential, not only in non-SOD1 ALS, but also for the treatment of FTD.Keywords
All Related Versions
Funding Information
- Rosetrees Trust (M249-F2)
- Brain Research Trust
This publication has 71 references indexed in Scilit:
- Degeneration and impaired regeneration of gray matter oligodendrocytes in amyotrophic lateral sclerosisNature Neuroscience, 2013
- Biology of the Heat Shock Response and Protein Chaperones: Budding Yeast (Saccharomyces cerevisiae) as a Model SystemMicrobiology and Molecular Biology Reviews, 2012
- Frequency of the C9orf72 hexanucleotide repeat expansion in patients with amyotrophic lateral sclerosis and frontotemporal dementia: a cross-sectional studyThe Lancet Neurology, 2012
- The molecular basis of the frontotemporal lobar degeneration–amyotrophic lateral sclerosis spectrumAnnals of Medicine, 2011
- Exome Sequencing Reveals VCP Mutations as a Cause of Familial ALSNeuron, 2010
- Hsp70 stabilizes lysosomes and reverts Niemann–Pick disease-associated lysosomal pathologyNature, 2010
- Valosin-containing protein (VCP) is required for autophagy and is disrupted in VCP diseaseJournal of Cell Biology, 2009
- Eukaryotic Stress Granules: The Ins and Outs of TranslationMolecular Cell, 2009
- The Shock of Aging: Molecular Chaperones and the Heat Shock Response in Longevity and Aging – A Mini-ReviewGerontology, 2009
- Valosin-containing protein disease: Inclusion body myopathy with Paget’s disease of the bone and fronto-temporal dementiaNeuromuscular Disorders, 2009